FRLN   $0.613  1.13% Market Closed

Freeline Therapeutics Holdings plc
Total Cash 29.45M
totalCashPerShare 0.451
EBITDA -64.84M
Total Debt 3.99M
quickRatio 1.847
currentRatio 1.945
Total Revenue 622.00K
debtToEquity 13.276
Revenue/Share 0.143
ROA -0.55503
ROE -1.01259
grossProfits
freeCashflow -41.18M
operatingCashflow -64.24M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -2409.6
profitMargins 0.0
enterpriseValue 398.13M
forwardPE -0.7705113
floatShares 26.80M
sharesOutstanding 4.36M
sharesShort 23.93K
sharesShortPriorMonth 47.97K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.46%
Short Ratio help_outline 1.92%
shortPercentOfFloat
impliedSharesOutstanding
bookValue 6.893
Price To Book help_outline 0.94
earningsQuarterlyGrowth
netIncomeToCommon -49.93M
trailingEps -11.40%
forwardEps -8.41%
enterpriseToEbitda -6.14
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.23 3Q 2023
institutionsCount 17
lastUpdated April 16, 2024, 8 p.m.